Overview
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Eligibility
Inclusion Criteria:
- undergoing robotic wedge resection or lobectomy for lung mass(es)
Exclusion Criteria:
- emergency case
- history of opiate abuse
- chronic pain syndrome
- intravenous drug use
- chronic use of oral steroids
- pregnancy
- imprisonment
- body weight lower than 70 kg
- liver failure
- uninsured patients
- non-verbal patients or patients who are unable to rate their pain on a visual analogue pain scale
- history of allergic reaction to any of the drugs used in the study: bupivacaine, liposomal bupivacaine, dexamethasone